Jul 17 |
Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets
|
Jun 17 |
Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina
|
May 15 |
Yield10 Bioscience GAAP EPS of -$4.77
|
May 15 |
Yield10 Bioscience Announces First Quarter 2024 Financial Results
|
May 15 |
Yield10 Bioscience to delist from Nasdaq
|
May 15 |
Yield10 Bioscience Announces Delisting from Nasdaq
|
May 3 |
Yield10 Bioscience files to sell units
|
Apr 25 |
Yield10 Bioscience files to sell 6.38M shares of common stock for holders
|
Apr 5 |
Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q4 2023 Earnings Call Transcript
|
Apr 2 |
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
|